A group, led by researchers from the University of Edinburgh, discovered that TLR2 helps control some of the body's defense mechanisms when cancerous mutations occur in cells.
Researchers investigating the mechanics of the early stages of lung cancer have identified a new potential treatment, which could also aid early detection of the disease.